Chronopharmacology of cardiovascular therapy

Blood Pressure Monitoring

Volumn 7, Issue 4, 2002, Pages 199-207

  White, William B ^a   LaRocca, Gina M ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Ambulatory blood pressure; Chronobiology; Chronopharmacology; Drug therapy

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENAZEPRIL; CALCIUM ANTAGONIST; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ISRADIPINE; NIFEDIPINE; NITRENDIPINE; QUINAPRIL; VERAPAMIL;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CHRONOBIOLOGY; CHRONOPHARMACOLOGY; CIRCADIAN RHYTHM; CLINICAL TRIAL; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ARRHYTHMIA; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; CATECHOLAMINES; CEREBROVASCULAR ACCIDENT; CHRONOTHERAPY; CIRCADIAN RHYTHM; CLINICAL TRIALS; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DILTIAZEM; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY, AMBULATORY; HEMODYNAMIC PROCESSES; HUMANS; MIDDLE AGED; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; SLEEP; VERAPAMIL;

EID: 0036694966     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-200208000-00001     Document Type: Review

References (65)

1. Smolensky MH, Haus E. Circadian rhythms and clinical medicine with applications to hypertension. Am J Hypertens 2001; 14:280S.
2. Smolensky MH, D'Alonzo GE. Medical chronobiology: concepts and applications. Am Rev Respir Dis 1993; 147:S2-S19.
3. Kloner RA, Poole WK, Perritt RL. When throughout the year is coronary death most likely to occur? A 12-year population-based analysis of more than 220,000 cases. Circulation 1999; 100:1630.
4. Phillips DP, Christenfeld N, Ryan NM. An increase in the number of deaths in the United States in the first week of the month: an association with substance abuse and other causes of death. N Engl J Med 1999; 341:93.
5. Evans C, Chalmers J, Capewell S, Redpath A, Finlayson A, Boyo J, et al. "I don't like Mondays". Day of the week of coronary heart disease deaths in Scotland: study of routinely collected data. BMJ 2000; 320:218.
6. Eiliott WJ. Cyclic and circadian variations in cardiovascular events. Am J Hypertens 2001; 14:291S.
7. Mansoor GA, White WB. Ambulatory blood pressure and cardiovascular risk stratification. J Vasc Med Biol 1994; 5:61-68.
8. White WB, Schulman P, McCabe EJ, Dey HM. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989; 261:873-877.
9. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313:1315-1322.
10. Cohen MC, Rohtla KM, Lavery CE, Muller JE, Mittleman MA, et al. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol 1997; 79:1512.
11. Elliott WJ. Circadian variation in the timing of stroke onset. Stroke 1998; 29:992.
12. Manfredini R, Portaluppi F, Zamboni P, Salmi R, Galleiani M. Circadian variation in spontaneous rupture of abdominal aorta. Lancet 1999; 353:643.
13. Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood pressure. Lancet 1978; 1:795-797.
14. White WB. Circadian variation of blood pressure. Am J Hypertens 1996; 9(4):26S-29S.
15. Mansoor GA, McCabe EJ, White WB. The long-term reproducibility of ambulatory blood pressure. J Hypertens 1994; 12:703-708.
16. White WB. Circadian variation of blood pressure and the assessment of antihypertensive therapy. Blood Press Monit 1999; 4(Suppl 1):S3-S6.
17. White WB, Morganroth J. Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy. Am J Cardiol 1989; 63:94-98.
18. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucei A, Battistelli M, et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994; 24:793-801.
19. Pickering TG. The clinical significance of diurnal blood pressure variations: dippers and non-dippers. Circulation 1990; 81:700-702.
20. Pickering TG. American Society of Hypertension Expert Panel: conclusions and recommendations on the clinical use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1996; 9:1-11.
21. Kario K, Matsuo T, Kobayashi H, Imaya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients: advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27:130-135.
22. Willich SN, Linderer T, Wegscheider K, Leizorovicz A, Alamercery I, Schroder R. Increased morning incidence of myocardial infarction in the ISAM study: absence with prior beta-adrenergic blockade. Circulation 1989; 80:853-858.
23. Tofler GH, Muller JE, Stone PH, Farman S, Solomon RE, Knatterud GL, et al. Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group. J Am Coll Cardiol 1992; 20:1049-1055.
24. Johnstone MT, Mittleman M, Tofler G, Muller JE. The pathophysiology of the onset of morning cardiovascular events. Am J Hypertens 1996; 9:22S-28S.
25. Mulcahy D, Keegan J, Cunningham D, Quyyumi A, Crean P, Parek A, et al. Circadian variation of total ischaemic burden and its alteration with anti-anginal agents. Lancet 1988; 2:755-759.
26. Rocco MB, Barry J, Campbell S, Nabel E, Cook EF, Goldman L, Selwyn AP. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987; 75:395-400.
27. Seigel D, Black DM, Seeley DG, Mulley SB Circadian variation in ventricular arrhythmias in hypertensive men. Am J Cardiol 1992; 69:344-347.
28. Raeder EA, Hahnloser SH, Graboys TB, Padrid PS, Lampert S, Lown B. Spontaneous variability and circadian distribution of ectopic activity in patients with malignant ventricuiar arrhythmia. J. Am Coll Cardiol 1988; 12:656-661.
29. Cornelissen G, Bakkan E, Delmore P, Orth-Gomer K, Akerstedt T, Caradentre O, et al. From various kinds of heart rate variability to chronocardiology. Am J Cardiol 1990; 66:863-868.
30. Twidale N, Taylor S, Heddle WF, Gyres BF, Tonkin AM. Morning increase in the time of onset of sustained ventricular tachycardia. Am J Cardiol 1989; 64:1204-1206.
31. Wood MA, Simpson PM, London WB, Stambler BS, Herre JM, Bernstein RC, et al. Circadian pattern of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 1995; 25:901-907.
32. Lampert R, Rosenfeld L, Batsford W, Lec F, McPherson C. Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter-defibrillators. Circulation 1994; 90:241-247.
33. Venditti FJ, John RM, Hull M, Tofler GH, Shahian DM, Martin DT. Circadian variation in defibrillation energy requirements. Circulation 1996; 94:1607-1612.
34. Lown B, Tykocinsky M, Garfein A, Brooks P. Sleep and ventricutar premature beats. Circulation 1973; 48:691-701.
35. Behrens S, Ehlers C, Bruggemann T, Ziss W, Dissman R, Galecka M, et al. Modification of the circadian pattern of ventricular tachyarrhythmias by beta-blocker therapy. Clin Cardiol 1997; 20:253.
36. Pitzalis MV, Mastropasqua F, Massari F, Totaro P, Scrutinio D, Rizzon P. Sleep suppression of ventricular arrhythmias: a predictor of beta-blocker efficacy. Eur Heart J 1996; 17:917-925.
37. Pietrucha A, Matysek Jerzy, Piwowarska W, Mroczek-Czernecka D, Gackowski, Stobierska B. Analysis of circadian distribution of premature ventricular contractions in patients after heart transplantation. PACE 1994; 17(part II):2064-2067.
38. Sousa J, Kou W, Calkins H, Rosenherk S, Kadis A, Morady F. Effect of epinephrine on the efficacy of the internal cardioverter-defibrillator. Am J Cardiol 1992; 69:509-512.
39. Wroe SJ, Sandercock P, Bamford J, Dennis M, Slattery J, Warkew C. Diurnal variation in incidence of stroke: Oxfordshire community project. BMJ 1992; 304:155-157.
40. Gallerani M, Manfredini R, Ricci L, Cocurullo A, Goldoni C, Bigoni M, et al. Chronobiological aspects of acute cerebrovascular diseases. Acta Neurol Scand 1993; 87:482-487.
41. Argentino C, Toni D, Rasura M, Violi F, Sacchettimz, Allegretta A, et al. Circadian variation in the frequency of ischemic stroke. Stroke 1990; 21:387-389.
42. Schillaci G, Verdecchia P, Benemio G, Porcellati C. Blood pressure rise and ischaemic stroke. Lancet 1995; 346:1366-1367.
43. Tsementzis SA, Gill JS, Hitchcock ER, Gillo K, Becrers DG. Diurnal variation of and activity during the onset of stroke. Neurosurgery 1985; 17:901-904.
44. White WB. A chronotherapeutic approach to the management of hypertension. Am J Hypertens 1996; 9:29S-33S.
45. Sloan MA, Price TR, Foulkes MA, Maler JR, Mohr JP, Hier DB, et al. Circadian rhythmicity of stroke onset: intracerebral and subarachnoid hemorrhage. Stroke 1992; 23:1420-1426.
46. Kleinpeter G, Schatzer R, Bock F. Is blood pressure really a trigger for the circadian rhythm of subarachnoid hemorrhage? Stroke 1995; 26:1805-1810.
47. Nakamura K, Oita J, Yamaguchi T. Nocturnal blood pressure dip in stroke survivors: a pilot study. Stroke 1995; 23: 1373-1378.
48. White WB. Ambulatory blood pressure monitoring in the evaluation of hypertension therapy. Cardiol Clin 1995; 13: 569-577.
49. Mansoor WB, White WB. Contribution of ambulatory blood pressure monitoring to the design and analysis of antihypertensive therapy trials. J Cardiovasc Risk 1994; 1:136-143.
50. Anwar YA, White WB. Chronotherapeutics for cardiovascular disease. Drugs 1998; 55:631.
51. Palatini P, Racioppa A, Raule B, Zaninotto M, Penzo M, Pessina AC. Effect of timing of administration on the plasma ACE inhibitor activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther 1992; 52:378-383.
52. Sundberg S, Luurila OJ, Kohvakka A, Gordin A. The circadian heart rate but not blood pressure profile is influenced by the timing of beta-blocker administration in hypertensives. Eur J Clin Pharmacol 1991; 40:435-436.
53. Greminger P, Suter PM, Holm D, Kobolt R, Vetter W. Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. Clin Investig 1994; 72:864-869.
54. Mengden T, Binswanger B, Spuhler T, Weisser B, Vetter W. The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. J Hypertens 1993; 11:1403-1411.
55. Lemmer B. Ambulatory blood pressure in antihypertensive therapy. Blood Press Monit 1996; 1:161-169.
56. White WB, Anders RJ, MacIntyre JM, Black HR, Seca DA, and the Verapamil Study Group. Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Am J Cardiol 1995; 76:375-380.
57. White WB, Black HR, Mehrotra D, Fakouhi TD. Effects of COER-verapamil on circadian variation of BP (dippers vs. non-dippers). Am J Cardiol 1997; 78: 469-474.
58. White WB, Black HR, Weber MA, Elliot WJ, Brasinski B, Fakouhi J. Comparison of effects of controlled-onset extended-release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart-rate blood pressure product. Am J Cardiol 1998; 81:424.
59. Cutler NR, Anders RJ, Jhee SS, Sramek JJ, Awan NA, Buttas J. Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris. Am J Cardiol 1995; 75:1102-1106.
60. Frishman WH, Glasser S, Stone P, Deedwania PC, Johnson M, Fakouhi TD. Comparison of controlled-onset, extended release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. Am J Cardiol 1999; 83:507.
61. Smith DHG, Neutel JM, Weber M. A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning. Am J Hypertens 2001; 14:14-19.
62. Black HR, Elliott WJ, Neaton JD, Granditz G, Gramsch P, Grim RH Jr. Rationale and design for the controlled onset verapamil investigation of cardiovascular endpoints (CONVINCE) trial. Controlled Clin Trials 1998; 19:370.
63. Black HR, Elliott WJ, Neaton JD, Granditz G, Gramsch P, Grim RH Jr. Baseline characteristics and early blood pressure control in the CONVINCE trial. Hypertens 2001; 37:12-18.
64. Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford JD, Willich SN, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987; 316: 1514-1518.
65. White WB. Ambulatory blood pressure monitoring in the evaluation of hypertension therapy. Cardiology Clinics of North America 1995; 13:569-577.